Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;8(6):698-711.
doi: 10.21037/gs.2019.11.18.

Diagnostic value of an automated breast volume scanner compared with a hand-held ultrasound: a meta-analysis

Affiliations

Diagnostic value of an automated breast volume scanner compared with a hand-held ultrasound: a meta-analysis

Xiaohui Zhang et al. Gland Surg. 2019 Dec.

Abstract

Background: The diagnostic performance of an automated breast volume scanner (ABVS) compared with that of a hand-held ultrasound (HHUS) for breast cancer remains unclear. We performed a meta-analysis to compare the diagnostic performances of the ABVS and HHUS for breast cancer.

Methods: We searched PubMed, EMBASE, Cochrane, and SinoMed databases to identify eligible studies up until November 14, 2018. Studies comparing ABVS and HHUS for differentiating benign and malignant breast tumors were included. A meta-analysis was performed to generate pooled diagnostic accuracy parameters [sensitivity, specificity, diagnostic odds ratio (DOR), area under the curve (AUC), and the Q* index] and detection rates for ABVS and HHUS.

Results: Nine studies involving 1,376 patients and 1,527 lesions were included in the meta-analysis for diagnostic accuracy. The pooled sensitivity was 0.93 [95% confidence interval (CI), 0.91-0.95] for ABVS and 0.90 (95% CI, 0.88-0.92) for HHUS, and the pooled specificity was 0.86 (95% CI, 0.83-0.88) for ABVS and 0.82 (95% CI, 0.79-0.84) for HHUS. The pooled DOR was 88.66 (95% CI, 51.44-152.78) for ABVS and 41.06 for HHUS (95% CI, 26.58-63.42). The AUC of the summary receiver operating characteristic (SROC) was 0.9496 for ABVS and 0.9143 for HHUS, and the Q* index was 0.8899 for ABVS and 0.8469 for HHUS. Meta-regression showed no significant difference between the diagnostic accuracy of ABVS and HHUS (P=0.0771). No publication bias was found. Thirteen published studies involving 1,047 pathologically confirmed malignant lesions were included to generate a pooled detection rate. The pooled detection rate was 1.00 (95% CI, 1.00-1.00) for both ABVS and HHUS, for which a publication bias was found.

Conclusions: ABVS can be used as an appropriate screening tool for breast cancer as well as HHUS in diagnostic accuracy and detection rate. Considering other advantages of ABVS including non-radioactivity, sensitivity to dense breast, three-dimensional reconstruction, time-saving and repeatability, it might be a promising screening tool for young or dense-breast women in the future.

Keywords: Automated breast volume scanner (ABVS); breast cancer; hand-held ultrasound (HHUS); meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Flow chart concerning selection of the included studies. a, eight studies were selected for both diagnostic accuracy and detection rate analysis.
Figure 2
Figure 2
Quality of studies included in diagnostic accuracy analysis. (A) Graph depicting the risk of bias and applicability concerns and (B) a summary of the risk of bias and applicability concerns.
Figure 3
Figure 3
The pooled sensitivity and specificity for ABVS and HHUS. The pooled sensitivity was 0.93 (95% CI, 0.91–0.95) for ABVS and 0.90 (95% CI, 0.88–0.92) for HHUS, and the specificity was 0.86 (95% CI, 0.83–0.88) for ABVS and 0.82 (95% CI, 0.79–0.84) for HHUS. (A) Sensitivity for ABVS; (B) specificity for ABVS; (C) sensitivity for HHUS; and (D) specificity for HHUS. ABVS, automated breast volume scanner; HHUS, hand-held ultrasound.
Figure 4
Figure 4
The pooled DOR for ABVS and HHUS. The pooled DOR was 88.66 (95% CI, 51.44–152.78) for ABVS and 41.06 (95% CI, 26.58–63.42). (A) The DOR for ABVS and (B) the DOR for HHUS. ABVS, automated breast volume scanner; HHUS, hand-held ultrasound; DOR, diagnostic odds ratio.
Figure 5
Figure 5
The AUC of the SROC and the Q* index for ABVS and HHUS. The AUC of the SROC was 0.9496 for ABVS and 0.9143 for HHUS, and the Q* index was 0.8899 for ABVS and 0.8469 for HHUS. (A) The SROC for ABVS; (B) the SROC for HHUS; and (C) the SROC for ABVS and HHUS combined in one figure. ABVS, automated breast volume scanner; HHUS, hand-held ultrasound; SROC, summary receiver operating characteristic.
Figure 6
Figure 6
Funnel plot for ABVS and HHUS. (A) The funnel plot for ABVS and (B) the funnel plot for HHUS. ABVS, automated breast volume scanner; HHUS, hand-held ultrasound.
Figure 7
Figure 7
The pooled detection rate for ABVS and HHUS. The pooled detection rate was 1.00 (95% CI, 1.00–1.00) for both ABVS and HHUS. (A) The pooled detection rate for ABVS and (B) the pooled detection rate for HHUS. ABVS, automated breast volume scanner; HHUS, hand-held ultrasound.
Figure 8
Figure 8
Funnel plot of 13 studies included in the detection rate analysis. (A) The funnel plot for ABVS and (B) the funnel plot for HHUS. ABVS, automated breast volume scanner; HHUS, hand-held ultrasound.
Figure S1
Figure S1
The pooled sensitivity was 0.91 (95% CI, 0.90–0.93) for ABVS and 0.91 (95% CI, 0.90–0.93) for HHUS, and the specificity was 0.82 (95% CI, 0.81–0.84) for ABVS and 0.78 (95% CI, 0.77–0.80) for HHUS. (A) Sensitivity for ABVS; (B) specificity for ABVS; (C) sensitivity for HHUS; (D) specificity for HHUS.
Figure S2
Figure S2
The pooled DOR was 56.59 (95% CI, 39.20–81.70) for ABVS and 41.21 (95% CI, 28.09–60.47) for HHUS. (A) DOR for ABVS; (B) DOR for HHUS.
Figure S3
Figure S3
The AUC of the SROC was 0.9426 for ABVS and 0.9269 for HHUS, and the Q* index and 0.8808 for ABVS and 0.8614 for HHUS. (A) SROC for ABVS; (B) SROC for HHUS.

Similar articles

Cited by

References

    1. Samadi P, Saki S, Dermani FK, et al. Emerging ways to treat breast cancer: will promises be met? Cell Oncol (Dordr) 2018;41:605-21. 10.1007/s13402-018-0409-1 - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. 10.3322/caac.21492 - DOI - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. 10.3322/caac.21442 - DOI - PubMed
    1. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36. 10.1056/NEJMoa062790 - DOI - PubMed
    1. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225:165-75. 10.1148/radiol.2251011667 - DOI - PubMed